Chestnut Hill, MANCT07568015Now EnrollingIRB Ready

Greater Trochanteric Pain Syndrome Clinical Trial in Chestnut Hill, MA

Access cutting-edge greater trochanteric pain syndrome treatment through this clinical trial at a research site in Chestnut Hill. Study-provided care at no cost to qualified participants.

Sponsored by Brixton Biosciences, Inc.

Quick Self-Assessment

See if you qualify for this Chestnut Hill location

Preparing your pre-screening questions…

Expert Care in Chestnut Hill

Access greater trochanteric pain syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related greater trochanteric pain syndrome treatment provided free

Apply for This Chestnut Hill Location

Check if you qualify for this greater trochanteric pain syndrome clinical trial in Chestnut Hill, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chestnut Hill

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chestnut Hill site if eligible
  4. 4Begin participation

About This Greater Trochanteric Pain Syndrome Study in Chestnut Hill

The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.

Sponsor: Brixton Biosciences, Inc.

Who Can Participate

Inclusion Criteria

Age 22 to 80, inclusive of any gender
Baseline pain intensity of \>5 of the Numeric Rating Scale (NRS) localized to the lateral aspect of the hip (with or without radiation to lateral thigh or buttock) despite current treatment
Tenderness to palpation of the peritrochanteric space of the lateral hip in adults with Greater Trochanteric Pain Syndrome.
At least 6 months of previous conservative treatments for subject's lateral hip pain (NSAID, acetaminophen, physical therapy, and/or cortisone injections) that are not currently providing relief
Agree to see study investigator and study team for hip pain during the study period
Willing/able to understand the informed consent form and provide written informed consent
Able to complete outcome measures (including electronic patient reported outcome measures)

Exclusion Criteria

Known allergy to glycerol, hyaluronic acid, poloxamer 407, or phosphate buffered saline
History of cryoglobulinemia
History of cold-induced auto-immune hemolytic anemia (e.g. paroxysmal cold hemoglobinuria or cold agglutinin disease)
History of cold urticaria
History of Chilblain's (pernio) disease in the lower extremities
History of Raynaud's disease
Open and/or infected wounds or active tumor at or near the treatment site
History of vascular surgery involving femoral vessels on theinjection side
History of hip surgery of any kind to the index side within the past 6 months (e.g., arthroscopy, arthroplasty, etc.)
History of trochanteric osteotomy, femoral osteotomy, amputation, or pseudoarthrosis.
Active bacterial or fungal infection that, at the discretion of the investigator, would preclude study participation
Currently taking \>60 MME/day
History of systemic inflammatory conditions such as rheumatoid arthritis
Bleeding disorders, unless appropriately stopped or reversed for the procedure at investigator's discretion
Any neuropathic pain condition (e.g. - complex regional pain syndrome, lumbar radiculopathy) in the area of pain
Presence of unstable psychiatric disease
Cryoneurolysis, thermal or pulsed radiofrequency ablation, or phenol injection for the index hip(s) within the past 12 months
Corticosteroid injection within the previous 3 months or orthobiologic therapy such as platelet rich plasma injections, or shockwave therapy for the index hip(s) within the previous 6 months
Known contraindication to use of a regional anesthetic block
Pregnant, nursing, or intent of becoming pregnant during the study period
Documented evidence of an overlapping pain pattern from another source that the Investigator believes to be indistinguishable from lateral hip pain
Lumbar or sacroiliac fusion within the previous 6 months
Any other condition (such as history of deep vein thrombosis, significant cardiovascular, renal failure/dialysis, hepatic or other systemic comorbidity/chronic pain condition including cancer) or circumstance that, in the opinion of the investigator, would compromise the safety of the subject or the quality of study data
Body habitus/hip anatomy that would preclude the use of the product injection needle size
Participation in any clinical study of a therapeutic investigational product within 30 days prior to enrollment
Pending litigation or disability status
Unwilling to refrain from any scheduled surgeries that would impact the collection of study endpoint data during the duration of the study
Subject is a prisoner

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chestnut Hill?

Yes, this clinical trial (NCT07568015) has an active research site in Chestnut Hill, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Greater Trochanteric Pain Syndrome Treatment Options in Chestnut Hill, MA

If you're searching for greater trochanteric pain syndrome treatment options in Chestnut Hill, MA, this clinical trial (NCT07568015) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chestnut Hill research site is actively enrolling participants for this clinical trial. You'll receive care from experienced greater trochanteric pain syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all greater trochanteric pain syndrome clinical trials near you to find additional studies recruiting in your area.

More Chronic Pain Trials in Chestnut Hill, MA

See all chronic pain clinical trials recruiting in Chestnut Hill — not just this study.

Browse Chronic Pain Trials in Chestnut Hill →

Browse More Trials by Condition

Chronic Pain TrialsInterstitial Cystitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Chestnut Hill?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chestnut Hill, MA